Emerging Tech White Papers
BIS Research is continuously scanning, analysing and predicting emerging technology themes and building knowledge-centric research products, to aid your growth trajectory.
BIS Research publishes emerging technology whitepapers to help our clients and partners keep abreast of the upcoming opportunities in the market.
BIS Research analyzes the end users, current innovations and technologies in the market, and the future of those technologies, which is possibly going to emerge, along with the adoption scenarios of silicone 3D printing material.
Biomarkers differentiating between diseases-affected and healthy individuals are relatively inadequate for the diagnosis of neurodegenerative diseases
Precision cardiology, at the outset, refers to the identification, diagnosis, and utilization of genetic biomarkers for the management of cardiac patients.
Autonomous modes of delivery ensure that people can receive their orders even during the ongoing pandemic without risking the lives of the delivery personnel. These vehicles also ensure that high-priority deliveries at hospitals are done instantly, without the delays caused due to the limited availability of delivery personnel.
3D printing technology holds the potential to bring about a paradigm shift in the manufacturing industry.
An Elite Compendium of Thought Leaders in Precision Medicine
An Elite Compendium of Thought Leaders in Healthcare Robotics
BIS Research identifies the N.E.E.D. concept that helps stakeholders make focused efforts on their areas of specialization to ensure the collective growth of electric vehicles.
Surgical procedures are one of the key practices of the healthcare industry. In the year 2018, the healthcare industry was said to record 354.3 million surgical procedures. Despite being such an essential component of healthcare framework, surgical environments persist to work in silos and lack effective integration between the preliminary components. According to a study conducted by the National Health Service (NHS) in the U.K., the inefficiency of operating environments resulted in a deficit of 291,327 operations in 2019.
Acknowledging this massive potential of AI in addressing the incidence of enormous diagnostic errors, and in enhancing the productivity specific to clinical workflows, 39% of healthcare providers in the U.S., plan to make substantial investments in AI. The global market for AI-based medical imaging is expected to surpass $9 billion mark by 2029.
With an enormous treasure trove of data about human genome produced by genomic research spawning a whole new era of digital technologies and sequencing platforms, researchers and clinicians now have more robust tools to study the role that genetic factors play in complex diseases. Today, in medicine, genomics application is actively making efforts in saving lives and driving billions of dollars of economic activity globally.
Genomics is already empowering healthcare industry to develop precise diagnostics, more effective treatment algorithms, and targeted therapeutics for some of the most complex diseases such as cancer, immunological disorders, and infectious diseases. Risk assessments, prenatal testing, screening, and diagnostic tests, and predictive testing are already being implemented and swift progress is being made in the emerging field of microbiome sequencing, pharmacogenomics, and drug development. With the rise of precision medicine, future healthcare treatments will be more tailored to a patient’s particular genetic makeup.
This whitepaper is a result of information collected from numerous interviews with global thought leaders across the agriculture supply chain, market analyses, and literature reviews. It intends to highlight the key concerns pertaining to the agriculture industry and how advanced farming practices hold potential for benefitting the sector. The report examines farmer perceptions regarding investing in innovative technologies. Further, the paper presents the solutions offered by the companies to encourage widespread adoption of precision agriculture technologies.
The onset of electric vehicle era is expected to have a notable impact on suppliers to the automotive industry. While electric vehicles provides a wide range of opportunities to the stakeholders in the automotive industry, The impending need to sustain the electric vehicle revolution urgently requires the adoption of certain modifications.
A potential solution to address the predominant causes of surgical errors is the incorporation of Virtual Reality (VR) Surgical Simulation systems.
Autonomous BVLOS flights are the next game changers in the commercial drone industry and present a multibillion-dollar business opportunity.
As per the World Bank Group, more than 90% of the world’s plastic waste does not get recycled and ends up as trash and litter. This results in most of the world’s plastic trash releasing toxins that contaminate the soil and groundwater and emitting dangerous greenhouse gases.
BIS Research and InsightMonk are excited to present the first edition of ‘The Top 25 Voices in Precision Medicine’, an elite compendium of thought leaders in precision medicine from across the globe.
In this report, BIS Research analyses every aspect of automotive cybersecurity to secure the future of mobility.
The automotive industry is undergoing an essential transformation, a kind that builds upon a concept once experimented a century ago, but remained an underdog owing to various performance gaps.
The advent of autonomous vehicles will bring a change in how the automotive marketplace works. It will not only be the playing field of major OEMs and distributor partners who will have a stake in the market but new and emerging players of different sectors will too form a role into shape the new autonomous vehicle market.
A wave of evolution is currently happening in the automotive, mobility and transportation, industries. This evolution, perhaps the most crucial for the 21st century, will change the way people travel and transform the way they live. However, the question is, when and how will this change happen?
BIS Research presents a white paper on Pharmacogenomics. The white paper highlights the emerging trends, technologies and clinical implementation of pharmacogenomics.